Enhancing AI-driven dermatologic care with multimodal image datasets

Dermatology
Skin Cancer
AI Development
AI Validation
Multimodal Imaging Data
Clinical Data
Pathology Data

Background

AI is increasingly used in dermatology to support tasks ranging from the diagnosis of melanoma, basal cell carcinoma, and cutaneous squamous cell carcinoma to the characterization of chronic inflammatory skin diseases, helping clinicians interpret dermatological images more consistently and efficiently1,2.

Histopathology-confirmed imaging plays a crucial role in training and validating such systems, ensuring that model outputs are anchored in robust diagnostic ground truth.

At the same time, real-world dermatology practice involves diverse image acquisition settings, making datasets that integrate macroscopic and dermoscopic images essential for clinically relevant AI.

Objective

A medical AI company engaged Aigora to curate a large, multimodal dermatology imaging dataset supporting the development and validation of AI algorithms for skin lesion detection and diagnosis.

Delivery

Aigora delivered a tailored multimodal imaging dataset combining clinical smartphone and dermoscopic images of the same lesions, linked to histopathologic diagnoses and structured metadata.

To learn more about Aigora’s experience in this field, read our research letter published in the Journal of the American Academy of Dermatology.

Dataset characteristics

  • Medical imaging

    Paired clinical smartphone and dermoscopic images

  • Clinical data

    Patient demographics, imaging device type, lesion body location, and physician free-text notes

  • Pathology data

    Histopathology-confirmed diagnosis and malignancy status

References

  1. Jairath N, Pahalyants V, Shah R, Weed J, Carucci JA, Criscito MC. Artificial Intelligence in Dermatology: A Systematic Review of Its Applications in Melanoma and Keratinocyte Carcinoma Diagnosis. Dermatol Surg. 2024;50(9):791-798. doi:10.1097/DSS.0000000000004223
  2. Tang AS, Wei ML, Haemel A, La C, Sirota M, Lee EY. Artificial intelligence-enabled precision medicine for inflammatory skin diseases. J Invest Dermatol. 2026;146(5):1195-1209.e4. doi:10.1016/j.jid.2025.10.596

‍

Project metrics
  • Number of images

    50,000+
  • Number of histopathology confirmed diagnoses

    20+
  • Number of variables per case

    5
  • Delivery timeline

    2 weeks

More case studies

See all

Enabling AI-driven research in retinal diseases with longitudinal ophthalmic imaging data

Ophthalmology
Biomarker Discovery
Treatment Response Assessment
Multimodal Imaging Data
Clinical Data
Read case study